4-androstene-3,17-diol has been researched along with androst-2-en-17-one in 1 studies
Studies (4-androstene-3,17-diol) | Trials (4-androstene-3,17-diol) | Recent Studies (post-2010) (4-androstene-3,17-diol) | Studies (androst-2-en-17-one) | Trials (androst-2-en-17-one) | Recent Studies (post-2010) (androst-2-en-17-one) |
---|---|---|---|---|---|
13 | 1 | 2 | 6 | 0 | 4 |
Protein | Taxonomy | 4-androstene-3,17-diol (IC50) | androst-2-en-17-one (IC50) |
---|---|---|---|
Aromatase | Homo sapiens (human) | 1.733 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alcaro, S; Amaral, C; Baptista, T; Carvalho, RA; Correia da Silva, G; Costa, G; Roleira, FM; Tavares da Silva, EJ; Teixeira, NA; Varela, C | 1 |
1 other study(ies) available for 4-androstene-3,17-diol and androst-2-en-17-one
Article | Year |
---|---|
New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation.
Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Binding Sites; Epoxy Compounds; Female; Humans; Inhibitory Concentration 50; Kinetics; Microsomes; Models, Molecular; Placenta; Pregnancy; Structure-Activity Relationship | 2012 |